ask
us
4th International PPRI Conference titled 'Medicines access challenge – The value of pricing and reimbursement policies' October 2019 ♦♦♦ Policy Principles on Cross-country Collaborations on Medicines' Pricing and Access ♦♦♦ CMS considers foreign drug prices to hold down Medicare Part B spending
...
Joan Gibert

Advisor

Advisor


Joan has a Life Science background, with a Medical degree from the Universitat Autònoma de Barcelona, and a degree in Health Care Management in ESADE Business School, Barcelona.

After some years of clinical practice, he started his career in the pharmaceutical industry more than 25 years ago, where he has developed a number of commercial and P&L roles in different geographies (Eastern Europe, Latin America, Portugal and mostly in Spain), managing cross-functional (marketing, sales, medical, finance, etc.) and cross-cultural teams at both country and regional level.

Joan has led brands in a number of therapeutic areas such as Dermatology, Endocrinology, Infectious Diseases, Ophthalmology, Oncology, Rheumathology, Rheumatology, and Transplantation. He has directly participated or supervised more than 30 launches of pharmaceutical brands or new indications in primary, specialty and hospital markets in 15 countries.

He also has developed the Market Access function for European countries, designing the PR&MA and LoE strategies for a number of global brands. Joan lives in Barcelona, Spain.

Back